This Anti-Aging Drug is Disrupting a $600 Billion Industry
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
More Videos
How the Charlotte Hornets Are Prioritizing Wellness with Judi Health
Shelly Cayette-Weston shares how the team’s partnership with Judi Health aims to boost community wellness and redefine athlete and fan health access.
The Future of Farming: InnerPlant CEO on Smart Crops That Emit Optical Signals
InnerPlant CEO Shely Aronov reveals how engineered crops like soybeans and corn emit signals when stressed—offering farmers early warnings to boost yields.
How $100K H1B Visas Could Reshape Hiring
Payoneer CEO John Caplan discusses the implications of $100K H1B visa requirements—and how they could reshape tech talent, hiring, and U.S. competitiveness.
Inside the Fed’s Numbers: Sarah Foster on U.S. Economic Momentum
Bankrate’s Sarah Foster breaks down Q2's 3.8% U.S. GDP growth and what it signals in light of recent Fed data and broader economic trends.
Go Fund Yourself: A New Way of Living
Torques Games is a new way to have fun outside, while mental health app Zulni offers tools for journaling, calming moods, and connection.
Russia Put A €100k Bounty On This Autonomous War Machine in Ukraine
Meet the autonomous tanks defending Ukraine's front lines and discover why Putin is now fighting to get a hold of one.
